Video - Thrombosis syndromes (hypercoagulability): Pathology review

00:00 / 00:00
More Videos

Acute intermittent porphyria

Autoimmune hemolytic anemia

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Sickle cell disease (NORD)

Folate (Vitamin B9) deficiency

Vitamin B12 deficiency

Alpha-thalassemia

Anemia of chronic disease

Beta-thalassemia

Iron deficiency anemia

Sideroblastic anemia

Anemia of chronic disease

Aplastic anemia

Aplastic anemia

Immune thrombocytopenia

Polycythemia vera (NORD)
Video Summary
Thrombosis syndromes, also known as hypercoagulability, are a group of disorders characterized by an increased tendency to develop blood clots. These disorders can be inherited or acquired, and they can affect different parts of the body, including the veins and arteries. Thrombosis syndromes can be inherited, like factor V Leiden, prothrombin gene mutation, protein C and S deficiency, antithrombin III deficiency, or acquired like antiphospholipid syndrome.
Diagnosis can be made based on clinical presentation, coagulation studies, more specific lab tests like ELISA for antiphospholipid antibodies, as well as genetic testing to detect the specific mutations. Treatment involves a combination of anticoagulant therapy, lifestyle modifications, and management of the underlying conditions. Anticoagulant medications, such as warfarin and heparin, can help prevent blood clots from forming or growing.